Cross-Neutralizing CRF01-AE-Infected Plasma from Malaysia Targets CD4-Binding Site of Human Immunodeficiency Virus Type-1 Envelope Glycoprotein

Human immunodeficiency virus type-1 (HIV-1) antigenic variation poses a great challenge for vaccine immunogen design to elicit broadly neutralizing antibodies (bNAbs). Over the last 10-15 years, great progress has been made to understand the conserved sites of sensitivity on HIV envelope glycoprotei...

Full description

Saved in:
Bibliographic Details
Main Authors: Ng, Qi Ron *, Tee, Kok Keng, Binley, James M, Tong, Tommy *
Format: Article
Published: Mary Ann Liebert 2022
Subjects:
Online Access:http://eprints.sunway.edu.my/3022/
https://doi.org/10.1089/aid.2020.0299
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first